Table 3.
Gender | Diagnosis year | Metropolitan | Nonmetropolitan | ||||
---|---|---|---|---|---|---|---|
| |||||||
HRa | CI | P value | HRa | CI | P value | ||
Male | |||||||
1991–1995 | Reference | Reference | |||||
1996–2000 | 0.90 | 0.79–1.03 | .13 | 0.71 | 0.51–0.99 | .04 | |
2001–2005 | 0.81 | 0.71–0.93 | .003 | 0.82 | 0.59–1.14 | .23 | |
2006–2010 | 0.69 | 0.59–0.79 | < .0001 | 0.70 | 0.49–0.98 | .04 | |
Female | |||||||
1991–1995 | Reference | Reference | |||||
1996–2000 | 1.01 | 0.88–1.16 | .84 | 1.11 | 0.80–1.54 | .53 | |
2001–2005 | 0.90 | 0.78–1.04 | .16 | 0.81 | 0.58–1.15 | .25 | |
2006–2010 | 0.76 | 0.65–0.88 | .0003 | 0.75 | 0.54–1.04 | .08 |
Bold indicates P < .05.
Abbreviations: HR = Hazard Ratio; CI = Confidence Interval
Estimates were based on models that adjusted for age at diagnosis and cancer stages.